It's not about when it's goes generic, but what is Novartis willing to settle out. There will be no warning date!
The next patent for Exelon patch listed in the FDA Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations) expires on Jan 8, 2019: http://www.accessdata.fda.gov/scripts/Cder/ob/docs/patexclnew.cfm?Appl_No=022083&Product_No=001&table1=OB_Rx.
You're dreaming, Patch will go generic by August if not sooner. Plenty of articles under google search support this.
Interesting how all the talk about your futures is how long Novartis can keep up the charade of adding value with new drugs rather then milk the system using highly paid pattent lawyers and loop holes in the patent system paid for with thier contributions to law makers and thier lobiests. It is no wonder that the majority of drugs developed in the last 30 years have been based on existing drugs, offer no significant improvement in clincial outcomes, screw the US heakthcare system and subsidize you parasites. It is very fun watching your lament before your asses are thrown in the street!
I believe they referenced the 13.3 only regarding August 2015, so what does that mean about 4.6 & 9.5?
Is it a wonder why the messaging has changed... They want us to sell with the goal to get to 13.3 in 60 days. I see another Lotrel story here.
